![Mark Forman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Dr. Mark Forman was previously employed as a Chief Medical Officer by Ventyx Biosciences, Inc., a Chief Medical Officer by Passage Bio, Inc., a Vice President by ACADIA Pharmaceuticals, Inc., and an Executive Director by Translational Medicine Accelerator.
He received his undergraduate degree from Yale University, a doctorate degree from The Rockefeller University and a doctorate degree from Duke University.
Former positions of Mark Forman
| Companies | Position | End |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 04/03/2026 |
| PASSAGE BIO, INC. | Chief Tech/Sci/R&D Officer | 02/08/2024 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2021 |
Translational Medicine Accelerator | Director/Board Member | - |
Education of Mark Forman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Translational Medicine Accelerator |
- Stock Market
- Insiders
- Mark Forman
